sattva neelapu, md, tells us about the results of the zuma-1 study in dlbcl presented at ash 2019
Published 4 years ago • 19 plays • Length 1:18
Download video MP4
Download video MP3
Similar videos
-
1:17
sattva neelapu, md, explains what the results of zuma-1 mean to dlbcl patients
-
1:41
sattva neelapu, md, regarding the zuma-1 two-year follow-up study in dlbcl
-
1:23
sattva neelapu, md, discusses efficacy results of the zuma-1 trial
-
3:48
sattva neelapu, md, discusses details of the zuma-12 trial presented at ash 2020
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
10:19
early t-cell precursor lymphoblastic leukemia (etp-all)
-
6:24
"diagnosis of lymphoma, basic guidelines" by dr. t. p. sahoo
-
1:27
anti scl 70 antibodies blood test
-
0:32
sattva neelapu, md shares safety results of the zuma-1 trial in patients with nhl
-
1:03
sattva neelapu, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
2:13
sattva neelapu | ash 2018 | results from the two-year follow-up of zuma-1
-
1:33
sattva neelapu, md, on real-world experience & clinical studies examining axicabtagene ciloleucel
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
1:47
meet lymphoma specialist sattva neelapu, m.d.
-
1:16
sattva neelapu: zuma-14
-
1:34
sattva neelapu, md, speculates on the future of first-line car t-cell therapy in lymphoma
-
2:32
zuma-1 update: durable survival in r/r dlbcl patients treated with axi-cel
-
1:37
sattva neelapu, md, considers the use of axicabtagene ciloleucel with elderly lymphoma patients
-
1:19
sattva neelapu, md, on novel agents and up-front approaches showing efficacy in lymphomas
-
3:09
sattva neelapu, md, discusses advancements in the management of car t-cell therapy aes
-
1:26
sattva neelapu, md, speculates on the future of car-t therapies in lymphoma
Clip.africa.com - Privacy-policy